LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
41 hedge funds and large institutions have $53.9M invested in La Jolla Pharmaceutical Company in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
41
Holding in Top 10
3
Calls
$47K
Puts
–
Top Buyers
| 1 | +$2.17M | |
| 2 | +$161K | |
| 3 | +$122K | |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$67.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.5K |
Top Sellers
| 1 | -$217K | |
| 2 | -$149K | |
| 3 | -$141K | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$133K |
| 5 |
Two Sigma Investments
New York
|
-$118K |
